A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: correlation between clinical responses and AUC pharmacokinetics
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Julie M Vose Bruce D. Cheson |
| Publication date | June 11, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |